TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Highlights Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Börse Stuttgart

Equities

2TZ

CNE100000924

Market Closed - Börse Stuttgart Other stock markets 07:05:25 27/06/2024 BST			5-day change	1st Jan Change
2.195 ^EUR	-1.86%		-6.38%	+20.99%

06-25	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Final Dividend for the Year Ended December 31, 2023, Payable July 12, 2024	CI
05-15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Final Dividend for the Year Ended December 31, 2023, Payable July 12, 2024	06-25	CI
Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3%	04-30	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Recommends Dividend	04-30	CI
Tianjin Pharmaceutical's Q1 Attributable Profit Slips 3%	04-30	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Tianjin Pharmaceutical Da Ren Tang's 2023 Profit Rises 14.5%	04-02	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Portion of Tianjin Pharmaceutical Controlling Shareholder's Shares Placed Under Judicial Freeze	01-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer